2.50
Hdl Handle:
http://hdl.handle.net/10541/68698
Title:
Technical aspects of cytoreductive surgery.
Authors:
Kusamura, Shigeki; O'Dwyer, Sarah T; Baratti, Dario; Younan, Rami; Deraco, Marcello
Abstract:
At the Fifth International Workshop on Peritoneal Surface Malignancy, in Milan, the consensus on technical aspects of cytoreductive surgery (CRS) for peritoneal surface malignancy was obtained through the Delphi process. Five conflicting points were discussed: radicality of the peritonectomy procedure, cytoreduction of neoplastic nodules <2.5 mm, the timing of bowel anastomoses in relation to hyperthermic intraperitoneal chemotherapy (HIPEC) and indications of protective ostomies. According to the panel of experts a partial parietal peritonectomy restricted to the macroscopically involved regions could be indicated in all listed clinical conditions with the exception of peritoneal mesothelioma. No expert was of the opinion that a radical parietal peritonectomy is advisable irrespective of the disease being treated. All the experts agreed that electrovaporization of small (<2.5 mm) non-infiltrating metastatic nodules in the mesentery would be appropriate, even if theoretically the HIPEC affords microscopic cytoreduction. The panel also agreed that in the closed technique for HIPEC administration the intestinal anastomoses should be fashioned after completion of the perfusion. Finally when considering the place for protective ostomies the experts voted for a flexible approach allowing the surgeon to exercise discretion for individual patients.
Affiliation:
Department of Surgery, National Cancer Institute of Milan, Milan, Italy.
Citation:
Technical aspects of cytoreductive surgery. 2008, 98 (4):232-6 J Surg Oncol
Journal:
Journal of Surgical Oncology
Issue Date:
15-Sep-2008
URI:
http://hdl.handle.net/10541/68698
DOI:
10.1002/jso.21058
PubMed ID:
18726883
Type:
Article
Language:
en
ISSN:
1096-9098
Appears in Collections:
All Christie Publications ; Surgery

Full metadata record

DC FieldValue Language
dc.contributor.authorKusamura, Shigeki-
dc.contributor.authorO'Dwyer, Sarah T-
dc.contributor.authorBaratti, Dario-
dc.contributor.authorYounan, Rami-
dc.contributor.authorDeraco, Marcello-
dc.date.accessioned2009-05-21T16:29:07Z-
dc.date.available2009-05-21T16:29:07Z-
dc.date.issued2008-09-15-
dc.identifier.citationTechnical aspects of cytoreductive surgery. 2008, 98 (4):232-6 J Surg Oncolen
dc.identifier.issn1096-9098-
dc.identifier.pmid18726883-
dc.identifier.doi10.1002/jso.21058-
dc.identifier.urihttp://hdl.handle.net/10541/68698-
dc.description.abstractAt the Fifth International Workshop on Peritoneal Surface Malignancy, in Milan, the consensus on technical aspects of cytoreductive surgery (CRS) for peritoneal surface malignancy was obtained through the Delphi process. Five conflicting points were discussed: radicality of the peritonectomy procedure, cytoreduction of neoplastic nodules <2.5 mm, the timing of bowel anastomoses in relation to hyperthermic intraperitoneal chemotherapy (HIPEC) and indications of protective ostomies. According to the panel of experts a partial parietal peritonectomy restricted to the macroscopically involved regions could be indicated in all listed clinical conditions with the exception of peritoneal mesothelioma. No expert was of the opinion that a radical parietal peritonectomy is advisable irrespective of the disease being treated. All the experts agreed that electrovaporization of small (<2.5 mm) non-infiltrating metastatic nodules in the mesentery would be appropriate, even if theoretically the HIPEC affords microscopic cytoreduction. The panel also agreed that in the closed technique for HIPEC administration the intestinal anastomoses should be fashioned after completion of the perfusion. Finally when considering the place for protective ostomies the experts voted for a flexible approach allowing the surgeon to exercise discretion for individual patients.en
dc.language.isoenen
dc.subjectPeritoneal Carcinomatosisen
dc.subjectCytoreductive Surgeryen
dc.subjectConsensusen
dc.subjectCancer of the Digestive Systemen
dc.subject.meshAnastomosis, Surgical-
dc.subject.meshChemotherapy, Adjuvant-
dc.subject.meshChemotherapy, Cancer, Regional Perfusion-
dc.subject.meshHumans-
dc.subject.meshIntestines-
dc.subject.meshOstomy-
dc.subject.meshPeritoneal Neoplasms-
dc.subject.meshPeritoneum-
dc.titleTechnical aspects of cytoreductive surgery.en
dc.typeArticleen
dc.contributor.departmentDepartment of Surgery, National Cancer Institute of Milan, Milan, Italy.en
dc.identifier.journalJournal of Surgical Oncologyen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.